Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing all 2 results
v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
v8i2: pp. 1- 24 Raymond S Strangways; Michael T Zugelder Personal Injury and wrongful death| Earnings Growth 1998
No products in the cart.